Physician profile
Mari Rossini
NPI 1770532871
$7,514.00
in general payments reported to CMS, 2019-2025
7 companies · $875 in 2025
The $875 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $677 · 2022: $2,612 · 2023: $2,712 · 2024: $638 · 2025: $875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,233 · Travel and Lodging: $1,930 · Grant: $62.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,233.04 |
| Travel and Lodging | $1,930.02 |
| Grant | $62.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,610.17 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Medtronic, INC. | $1,989.10 | 2023-2024 | Corevalve Evolut R |
| Shockwave Medical, INC | $691.65 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.06 | 2022-2024 | Lifevest |
| Boston Scientific Corporation | $32.12 | 2024 | Watchman Flx |
| Abbott Laboratories | $27.90 | 2024 | Amplatzer Talisman |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mari Rossini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.